TMO

Thermo Fisher Canadian Hedged Depositary Receipts

Stock
Stock
ISIN: CA88355G1000
Ticker: TMO
CA88355G1000
TMO

Price

Price

CHART BY

Historical dividends and forecast

Thermo Fisher Canadian Hedged Depositary Receipts has so far distributed $0.0358 in 2026. The next dividend will be paid on 22.10.2026

$0.0428

CHART BY

Frequently asked questions

The market capitalization of Thermo Fisher Canadian Hedged Depositary Receipts is $6.40B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Thermo Fisher Canadian Hedged Depositary Receipts is 0.95. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Thermo Fisher Canadian Hedged Depositary Receipts's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $25.70. EPS indicates the company's profitability on a per-share basis.
Over the trailing twelve months, Thermo Fisher Canadian Hedged Depositary Receipts reported a revenue of $64.05B.
Yes, Thermo Fisher Canadian Hedged Depositary Receipts is paying dividends. The next payment is scheduled for 22.10.2026, with an expected amount of .
Thermo Fisher Canadian Hedged Depositary Receipts's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $16.29B. EBITDA measures the company's overall financial performance.
Thermo Fisher Canadian Hedged Depositary Receipts has a free cash flow of $10.17B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Thermo Fisher Canadian Hedged Depositary Receipts employs approximately 125,000 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

Financials

Market Cap 
$6.40B
EPS (TTM) 
$25.70
P/E ratio (TTM) 
0.95
Revenue (TTM) 
$64.05B
EBITDA (TTM) 
$16.29B
Free Cashflow (TTM) 
$10.17B

Pricing

52W span
$11.44$17.55

Information

Thermo Fisher Scientific Inc. offers products and services to customers working in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of disease. The Analytical Instruments segment offers instruments and supporting consumables, software and services. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments and associated products to healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers outsourced services used by the pharmaceutical and biotech industries for drug development, clinical research, clinical trials services and commercial drug manufacturing. The company was founded in July 1956 and is headquartered in Waltham, MA.

Employees
125,000
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
CA88355G1000
Primary Ticker
TMO
Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin